Control of cell survival by IGF signaling pathways

Growth Hormone and IGF Research

Volumn 12, Issue 4, 2002, Pages 193-197

  Vincent, Andrea M ^a   Feldman, Eva L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Akt protein kinase B; Apoptosis; Insulin like growth factor I; Phosphorylation

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; SOMATOMEDIN; SOMATOMEDIN RECEPTOR;

APOPTOSIS; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0036669037     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(02)00017-5     Document Type: Review

References (44)

1. Alison MR, Sarraf CE. Apoptosis a gene-directed programme of cell death. J R Coll Physicians Lond 1992; 26: 25-35.
2. Joaquin AM, Gollapudi S. Functional decline in aging and disease: a role for apoptosis. J Am Geriatr Soc 2001; 49: 1234-1240.
3. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281: 1312-1316.
4. Fesik SW. Insights into programmed cell death through structural biology. Cell 2000; 103: 273-282.
5. Zamzami N, Kroemer G. The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2001; 2: 67-71.
6. Allan GJ, Flint DJ, Patel K. Insulin-like growth factor axis during embryonic development. Reproduction 2001; 122: 31-39.
7. Tumber A, Meikle MC, Hill PA. Autocrine signals promote osteoblast survival in culture. J Endocrinol 2000; 167: 383-390.
8. Ge NL, Rudikoff S. Insulin-like growth factor I is a dual effector of multiple myeloma cell growth. Blood 2000; 96: 2856-2861.
9. Hong F, Kwon SJ, Jhun BS, et al. Insulin-like growth factor-1 protects H9c2 cardiac myoblasts from oxidative stress-induced apoptosis via phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways. Life Sci 2001; 68: 1095-1105.
10. van Golen CM, Feldman EL. Insulin-like growth factor I is the key growth factor in serum that protects neuroblastoma cells from hyperosmotic-induced apoptosis. J Cell Physiol 2000; 182: 24-32.
11. Ahmad S, Singh N, Glazer RI. Role of AKT1 in 17beta-estradiol and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells. Biochem Pharmacol 1999; 58: 425-430.
12. Baxter RC. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endo Metab 2000; 278: E967-E976.
13. Baxter RC. Signalling pathways involved in antiproliferative effects of IGFBP-3: a review. Mol Pathol 2001; 54: 145-148.
14. Perks CM, McCaig C, Holly JM. Differential insulin-like growth factor (IGF)-independent interactions of IGF binding protein-3 and IGF binding protein-5 on apoptosis in human breast cancer cells. Involvement of the mitochondria. J Cell Biochem 2000; 80: 248-258.
15. Guan J, Waldvogel HJ, Faull RL, Gluckman PD, Williams CE. The effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate in different regions following hypoxic-ischemic brain injury in adult rats. Neuroscience 1999; 89: 649-659.
16. Resnicoff M, Burgaud JL, Rotman HL, Abraham D, Baserga R. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res 1995; 55: 3739-3741.
17. Osipo C, Dorman S, Frankfater A. Loss of insulin-like growth factor II receptor expression promotes growth in cancer by increasing intracellular signaling from both IGF-I and insulin receptors. Exp Cell Res 2001; 264: 388-396.
18. Chen H, Yan GC, Gishizky ML. Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors. Cell Growth Differ 1998; 9: 939-947.
19. O'Connor R, Kauffmann-Zeh A, Liu YM, et al. Identification of domains of the insulin-like growth factor,l receptor that are required for protection from apoptosis. Mol Cell Biol 1997; 17: 427-435.
20. Takahashi K, Yonezawa K, Nishimoto I. Insulin-like growth factor I receptor activated by a transmembrane mutation. J Biol Chem 1995; 270: 19041-19045.
21. Dudek H, Datta SR, Franke TF, et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997; 275: 661-665.
22. Bai MZ, Pollman MJ, Inishi Y, Gibbons GH. Regulation of vascular smooth muscle cell apoptosis. Modulation of bad by a phosphatidylinositol 3-kinase-dependent pathway. Circ Res 1999; 85: 229-237.
23. Peruzzi F, Frisco M, Dews M, et al. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol 1999; 19: 7203-7215.
24. Kermer P, Klocker N, Labes M, Bahr M. Insuhn-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI3-K-dependent akt phosphorylation and inhibition of caspase-3 In vivo. J Neurosci 2000; 20: 722-728.
25. Brunet A, Bonni A, Zigmond MJ, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96: 857-868.
26. Kops GJ, Burgering BM. Forkhead transcription factors are targets of signalling by the proto-oncogene PKB (C-AKT). J Anat 2000; 197(Pt 4): 571-574.
27. Chrysis D, Calikoglu AS, Ye P, D'Ercole AJ. Insulin-like growth factor-I overexpression attenuates cerebellar apoptosis by altering the expression of Bcl family proteins in a developmentally specific manner. J Neurosci 200 1; 21: 1481-1489.
28. Leverrier Y, Thomas J, Mathieu AL, Low W, Blanquier B, Marvel J. Role of PI3-kinase in Bcl-X induction and apoptosis inhibition mediated by IL-3 or IGF-1 in Baf-3 cells. Cell Death Differ 1999; 6: 290-296.
29. Heck S, Lezoualc'h F, Engert S, Behl C. Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB. J Biol Chem 1999; 274: 9828-9835.
30. Yamaguchi A, Tamatani M, Matsuzaki H, et al. Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptinal activity of p53. J Biol Chem 2001; 276: 5256-5264.
31. Grimberg A. P53 and IGFBP-3: apoptosis and cancer protection. Mol Genet Metab 2000; 70: 85-98.
32. Tong N, Sanchez JF, Maggirwar SB, et al. Activation of glycogen synthase kinase 3beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. Fur J Neurosci 2001; 13: 1913-1922.
33. Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem 1995; 270: 14843-14846.
34. Dews M, Prisco M, Peruzzi F, Romano G, Morrione A, Baserga R. Domains of the insulin-like growth factor I receptor required for the activation of extracellular signal-regulated kinases. Endocrinology 2000; 141: 1289-1300.
35. Peruzzi F, Prisco M, Morrione A, Valentinis B, Baserga R. Anti-apoptotic signaling of the insulin-like growth factor-I receptor through mitochondrial translocation of c-Raf and Nedd4. J Biol Chem 2001; 276: 25990-25996.
36. Kim B, Cheng H-L, Margolis B, Feldman EL. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling. J Biol Chem 1998; 273: 34543-34550.
37. Valentinis B, Morrione A, Peruzzi F, Frisco M, Reiss K, Baserga R. Anti-apoptotic signaling of the IGF-I receptor in fibroblasts following loss of matrix adhesion. Oncogene 1999; 18: 1827-1836.
38. Scheid MP, Schubert KM, Duronio V. Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase. J Biol Chem 1999; 274: 31108-31113.
39. Cheng H-L, Feldman EL. Bidirectional regulation of p38 kinase and c-Jun N-terminal protein kinase by insulin-like growth factor-I. J Biol Chem 1998; 273: 14560-14565.
40. Pugazhenthi S, Boras T, O'Connor D, Meintzer MK, Heidenreich KA, Reusch JE. Insulin-like growth factor I-mediated activation of the transcription factor cAMP response element-binding protein in PC12 cells. Involvement of p38 mitogen-activated protein kinase-mediated pathway. J Biol Chem 1999; 274: 2829-2837.
41. Okubo Y, Blakesley VA, Stannard B, Gutkind S, Le Roith D. insulin-like growth factor-I inhibits the stress-activated protein kinase/c-Jun N-terminal kinase. J Biol Chem 1998; 273: 25961-25966.
42. Blair LA, Marshall J. IGF-1 modulates N and L calcium channels in a PI 3-kinase-dependent manner. Neuron 1997; 19: 421-429.
43. Blair LA, Bence-Hanulec KK, Mehta S, Franke T, Kaplan D, Marshall J. Akt-dependent potentiation of L channels by insulin-like growth factor-1 is required for neuronal survival. J Neurosci 1999; 19: 1940-1951.
44. Lai EC, Felice KJ, Festoff BW, et al. Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group. Neurology 1997; 49: 1621-1630.